Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

InspireMD (NSPR) Income towards Parent Company (2016 - 2025)

Historic Income towards Parent Company for InspireMD (NSPR) over the last 16 years, with Q3 2025 value amounting to -$13.1 million.

  • InspireMD's Income towards Parent Company fell 5423.07% to -$13.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$46.9 million, marking a year-over-year decrease of 5661.57%. This contributed to the annual value of -$32.0 million for FY2024, which is 6069.99% down from last year.
  • Per InspireMD's latest filing, its Income towards Parent Company stood at -$13.1 million for Q3 2025, which was down 5423.07% from -$13.0 million recorded in Q2 2025.
  • InspireMD's Income towards Parent Company's 5-year high stood at -$3.2 million during Q1 2021, with a 5-year trough of -$13.1 million in Q3 2025.
  • For the 5-year period, InspireMD's Income towards Parent Company averaged around -$6.6 million, with its median value being -$5.3 million (2023).
  • In the last 5 years, InspireMD's Income towards Parent Company plummeted by 8546.7% in 2021 and then soared by 223.16% in 2023.
  • Quarter analysis of 5 years shows InspireMD's Income towards Parent Company stood at -$4.1 million in 2021, then fell by 18.88% to -$4.8 million in 2022, then decreased by 20.57% to -$5.8 million in 2023, then plummeted by 61.28% to -$9.4 million in 2024, then tumbled by 39.33% to -$13.1 million in 2025.
  • Its Income towards Parent Company stands at -$13.1 million for Q3 2025, versus -$13.0 million for Q2 2025 and -$11.5 million for Q1 2025.